Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 23 for “"Lassa fever"”.
-
Viral haemorrhagic fevers in pregnancy with a focus on lassa fever
<p>The viral haemorrhagic fevers (VHFs) are thought to be major causes of morbidity and mortality in pregnant women. However, there remains a paucity of evidence in pregnancy, due in part to the exclusion of pregnant women from clinical trials. The recent occurrence of large VHF outbreaks, coupled …
-
CRISPR-based point-of-care detection of Ebola virus and Lassa fever
… pathogens (HCPs) such as viral hemorrhagic fevers (VHFs), polymerase chain reaction (PCR), has limited feasibility at the point-of-care (POC) due to its centralized location, high cost, and relatively long turnaround time. POC tests (POCTs) provide rapid results in the field during outbreak …
-
Development of rationally designed live attenuated vaccines for Lassa fever and Venezuelan equine encephalitis.
Lassa Virus (LASV) and Venezuelan Equine Encephalitis Virus (VEEV) are two single stranded RNA viruses belonging to the Arenavirus and Alphavirus families, respectively. Both are emerging pathogens without approved vaccines or treatments. VEEV is an important biothreat pathogen because it has been …
-
Improving the care of Lassa fever patients: re-evaluating the use of Ribavirin and characterising cardiovascular function
<p>Lassa fever is a viral haemorrhagic fever, endemic to several West African countries. Case fatality rates average 30% across the literature. Ribavirin, a broad-spectrum antiviral agent, has been used to treat Lassa fever for four decades. Ribavirin is a pro-drug, metabolised to its active …
-
Pichinde virus infection of outbred Hartley guinea pigs and mice as small animal models of human Lassa fever
… that can cause severe and deadly hemorrhagic fever infections in Africa and South America, including Lassa virus that causes Lassa fever in several countries in west Africa. There are currently no vaccines and very limited therapeutics available for Lassa fever. There are also several …
-
Improving efficacy endpoints in clinical trials for outbreak-prone infectious diseases
… these issues through three case studies: Lassa fever, mpox, and bubonic plague. A mixed-methods approach was used, including systematic reviews to examine outcome selection challenges, validity and reliability studies to evaluate measurement tools, and a retrospective cohort study. In the …
-
Vaccine development and deep immune profiling in preclinical models of emerging outbreak viral pathogens
… viral pathogens of epidemic/pandemic potential: Lassa virus (LASV) and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).</p> <p>LASV is endemic to regions in West Africa and circulates in rodent populations. Upon transmission to humans, LASV infection may cause an acute febrile …
-
Development and characterization of Lassa virus vaccines and mouse model
Lassa virus (LASV) is the causative agent of a hemorrhagic fever endemic in West Africa, which results in over 200,000 infections and 3000 to 5000 deaths annually. It has previously been demonstrated that a live attenuated recombinant Vesicular Stomatitis Virus expressing the LASV glycoproteins …
-
Pro-inflammatory cytokines promote viral replication and cell cycle mediators in arenavirus-induced hepatitis.
Lassa virus (LASV) is an arenavirus and causative agent of Lassa fever (LF), a viral hemorrhagic fever in West Africa for which there is no vaccine. Lymphocytic choriomeningitis virus (LCMV), is used as a surrogate to mimic LASV-induced liver pathology. LCMV-WE, not LCMV-ARM, causes disease in …
-
Utilizing blood-based biomarkers to characterize pathogenesis and predict mortality in viral hemorrhagic fevers
Hemorrhagic fever viruses are a major public health threat in Sub-Saharan Africa. These kinds of viruses cause symptoms ranging from non-specific fevers and body aches to severe, life-threatening bleeding, shock, and multi-organ failure. Previously discovered hemorrhagic fever viruses can cause …
-
MAPPING EPITOPES AND RECEPTOR BINDING DETERMINANTS OF LASSA VIRUS GLYCOPROTEIN USING Qβ PHAGE DISPLAY
Lassa virus (LASV) is a highly infectious pathogen responsible for Lassa fever, a severe hemorrhagic disease endemic to West Africa. Despite its significant health burden, there are currently no widely available vaccines or effective antiviral treatments. The only surface glycoprotein (GP) of LASV …
-
ANIMAL MODELS FOR BEHAVIORAL CHANGES OR HEARING LOSS UPON ACUTE VIRUS INFECTIONS
… Sensorineural hearing loss is detected in 25% of Lassa fever patients and up to 90% of encephalitic alphavirus infections result in severe behavioral changes. Well-established murine models are available to study each of these viruses’ initial infection, including the wild-type C57BL/6 model of …
-
Development of a Lassa/Rabies virus vaccine based on the rabies vector
Lassa fever (LF), is a viral hemorrhagic fever caused by Lassa virus (LASV), for which neither an approved vaccine or effective treatment is available. LASV is an endemic virus in western Africa and a major health and economic burden, causing an estimate 100,000-300,000 infections yearly, with the …
-
Mapping the global distribution of zoonoses of public health importance
… the mapping of the suite of viral haemorrhagic fevers by assessing the distribution of Crimean-Congo haemorrhagic fever and Lassa fever. Finally, Chapter 8 considers the risk that these viral haemorrhagic fevers present to the wider African continent, quantifying potential risk of spillover …
-
PREVENTING THE NEXT PANDEMIC: ELUCIDATING THE ROLE OF THE LASSA VIRUS FUSION DOMAIN IN INFECTIONS
Infection with Lassa virus (LASV), an arenavirus endemic to West Africa, results in Lassa fever (LF) – a severe hemorrhagic fever with high morbidity and mortality. There are presently no FDA-approved therapeutic options for the explicit treatment of LF, largely due to a lack of knowledge …
-
Koutango: under reported arboviral disease in West Africa
… Leone, after ruling out endemic malaria and Lassa fever. Related to the laboratory results of the testing, three exploratory experiments on Koutango virus were developed. The experiment directed special interest into the vector mosquito Aedes aegypti and its ability to uptake, disseminate, …
-
Circulating immune response to Ebola virus disease in humans and non-human primates
… performed on other severe viral diseases such as Lassa Fever and Marburg Fever.
-
Cytokine patterns in a comparative model of arenavirus infection: Implications for virulence and control of viral replication
… Pichinde provides an animal model for human Lassa fever, a disease that affects 300,000 to 500,000 people a year in western Africa. Low passage Pichinde virus (P2) induces a mild disease with low viremia, while high passage Pichinde (P18) induces a severe disease with high viremia, ending in …
-
UNRAVELING THE ROLE OF LASSA VIRUS TRANSMEMBRANE DOMAIN IN VIRAL FUSION MECHANISM
Lassa virus (LASV) is the most prevalent member of the arenavirus family and the causative agent of Lassa fever, a viral hemorrhagic fever. Although there are annual outbreaks in West Africa and recently isolated cases worldwide, no current therapeutics or vaccines pose LASV as a significant global …
-
Computational identification and mechanistic evaluation of novel Lassa virus entry inhibitors
Lassa virus, a zoonotic Old World mammarenavirus endemic to West Africa, causes significant disease burden and is a serious public health threat. With an estimated 2.7 million infections per year, it is categorized by the World Health Organization as a priority pathogen for research in emergency …
Page 1 of 2